Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 4 Association of subsequent pulselessness status with outcomes

From: Early bolus epinephrine administration during pediatric cardiopulmonary resuscitation for bradycardia with poor perfusion: an ICU-resuscitation study

 

Never developed

pulselessness

(n = 68)

Developed subsequent pulselessness

(n = 65)

Developed pulselessness and subsequently had at least one return to bradycardia with poor perfusion

(n = 53)

P-value

Sustained ROSC

57 (84%)

28 (43%)

33 (62%)

 < 0.001

Survival to hospital discharge

45 (66%)

31 (48%)

30 (57%)

0.10

Survival to hospital discharge with favorable neurologic outcomea

45 (66%)

30 (46%)

29 (55%)

0.07

Survival to hospital discharge with PCPC of 1, 2, or no change from baseline

42 (62%)

26 (40%)

27 (51%)

0.045

  1. Bold value indicates the primary outcome
  2. Subsequent pulselessness status of the 186 patients in the cohort with evaluable arterial blood pressure data are included
  3. aFavorable neurologic outcome was defined as a PCPC of 1, 2, 3, or no change from baseline
  4. ROSC, return of spontaneous circulation
Back to article page

Critical Care

ISSN: 1364-8535